Correction to: TCR-T cell therapy: current development approaches, preclinical evaluation, and perspectives on regulatory challenges (Journal of Translational Medicine, (2024), 22, 1, (897), 10.1186/s12967-024-05703-9)

1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Following publication of the original article [1], we have been notified that Funding note was published incorrectly. It is now as follows: This study was funded by Academic Leadership Program Priority 2030, Russian Science Foundation, project number 21-65-00004. It should be as follows: Preparing of Sects. 1–3 were supported by Academic Leadership Program Priority 2030 proposed by the Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), preparing of Sects. 4–5 were supported by the Russian Science Foundation, project number 21-65-00004 (https://rscf.ru/project/21-65-00004/, accessed on 20 April 2021). The original article was updated.

Cite

CITATION STYLE

APA

Golikova, E. A., Alshevskaya, A. A., Alrhmoun, S., Sivitskaya, N. A., & Sennikov, S. V. (2024, December 1). Correction to: TCR-T cell therapy: current development approaches, preclinical evaluation, and perspectives on regulatory challenges (Journal of Translational Medicine, (2024), 22, 1, (897), 10.1186/s12967-024-05703-9). Journal of Translational Medicine. BioMed Central Ltd. https://doi.org/10.1186/s12967-024-05863-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free